Neural Cell News Volume 17.02 | Jan 18 2023

    0
    16







    2023-01-18 | NCN 17.02


    Neural Cell News by STEMCELL Technologies
    Vol. 17.02 – 18 January, 2023
    TOP STORY

    Immunity to the Microbiota Promotes Sensory Neuron Regeneration

    Researchers showed that, upon injury, adaptive responses to the microbiota directly promoted sensory neuron regeneration.
    [Cell]

    AbstractGraphical Abstract
    Register for the 3rd Neuroepigenetics & Neuroepitranscriptomics Conference.
    PUBLICATIONSRanked by the impact factor of the journal

    Massively Parallel Identification of mRNA Localization Elements in Primary Cortical Neurons

    Scientists described a novel neuronal zipcode identification protocol called N-zip that can identify zip codes across hundreds of 3′ untranslated regions.
    [Nature Neuroscience]

    Full Article

    Hemorrhage of Human Fetal Cortex Associated with SARS-CoV-2 Infection

    Investigators reported the presence of SARS-CoV-2 in first and second-trimester fetal brain tissue in association with cortical hemorrhages.
    [Brain]

    Full Article

    PRMT1 Driven PTX3 Regulates Ferritinophagy in Glioma

    The authors described ferritinophagy in isocitrate dehydrogenase (NADP(+)) 1 mutant gliomas with mechanistic details. They suggested that the PRMT1-PTX3 ferritinophagy regulatory circuit could be exploited for therapeutic gains.
    [Autophagy]

    Abstract

    Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities

    Scientists analyzed TCGA databases and found that co-mutations of PTEN and TP53 were most significantly enriched in human high-grade gliomas.
    [Cancer Research]

    Abstract

    Interferon Regulates Neural Stem Cell Function at All Ages by Orchestrating mTOR and Cell Cycle

    Researchers established the molecular mechanisms of interferon in stem cells and interferons as genuine regulators of stem cell homeostasis and a potential therapeutic target to repair the aging brain.
    [Embo Molecular Medicine]

    Full ArticleGraphical Abstract

    Dynamic Physiological α-Synuclein S129 Phosphorylation Is Driven by Neuronal Activity

    Researchers used multiple approaches to show for the first time that SerineS129 functioned as a physiological regulator of neuronal activity.
    [Npj Parkinson’s Disease]

    Full Article

    Intellectual Disability and Abnormal Cortical Neuron Phenotypes in Patients with Bloom Syndrome

    Scientists examined and clarified the abnormality of the cortical neuron phenotypes by generating Bloom Syndrome-induced pluripotent stem cells.
    [Journal Of Human Genetics]

    Abstract

    Effects of a Monoclonal Antibody against (Pro)renin Receptor on Gliomagenesis

    Investigators examined the effects of a monoclonal antibody against (Pro)renin receptor on gliomagenesis. Human glioma cell lines, U251MG and U87MG, and a glioma stem cell line, MGG23, were used for the in vitro study.
    [Scientific Reports]

    Full Article
    Click here to register for an on-demand neural induction course
    REVIEWS

    Blood-to-Brain Communication in Aging and Rejuvenation

    Researchers discuss blood-to-brain communication from a systems physiology perspective with an emphasis on blood-derived signals as potent drivers of both age-related brain dysfunction and brain rejuvenation.
    [Nature Neuroscience]

    Full Article

    Neuroinflammation Mechanisms of Neuromodulation Therapies for Anxiety and Depression

    The authors summarize clinical and animal studies on inflammation in neural circuits related to anxiety and depression and the evidence that neuromodulation therapies regulate neuroinflammation in the treatment of neurological diseases.
    [Translational Psychiatry]

    Full Article
    INDUSTRY AND POLICY NEWS

    Israel-Based Clearmind Announces Additional Positive Results from the Third Part of its Pre-Clinical Study for Cocaine Addiction Treatment

    Clearmind Medicine, Inc. announced additional positive pre-clinical results in its ongoing series of research studies conducted to illuminate the tremendous potential of MEAI and its effect on substance-use disorder.
    [Clearmind Medicine, Inc.]

    Press Release

    Day One Announces Topline Data from Pivotal Phase II FIREFLY-1 Trial Demonstrating Meaningful Responses with Tovorafenib in Recurrent or Progressive Pediatric Low-Grade Glioma

    Day One Biopharmaceuticals announced positive topline results from the ongoing, open-label, pivotal Phase II FIREFLY-1 trial evaluating the investigational agent, tovorafenib, as a monotherapy in recurrent or progressive pediatric low-grade glioma.
    [Day One Pharmaceuticals, Inc.]

    Press Release
    FEATURED EVENT

    ESMO Targeted Anticancer Therapies Congress 2023

    March 6 – 8, 2023
    Paris, France

    > See All Events

    JOB OPPORTUNITIES

    PhD position – Glial-Immune Interactions

    University of Melbourne – Melbourne, Victoria, Australia

    Assistant Professor – Physiology

    Midwestern University – Glendale, Arizona, United States

    Postdoctoral Position – Neuroproteomics

    The University of Southern Denmark – Odense, Denmark

    Group Leader – Cell Biology

    Pompeu Fabra University – Barcelona, Spain

    Research Assistant – Human Brain Organoids

    Baylor College of Medicine – Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Neural Cell News Twitter